Alexion to Report First Quarter Results and Provide Update on COVID-19 on Wednesday, May 6th, 2020
Company Announces 2020 Annual Shareholder Meeting To Be Held Virtually
BOSTON--(BUSINESS WIRE)-- Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2020 before the US financial markets open on May 6, 2020. Following the release of the financial results, Alexion management will conduct a conference call and audio webcast at 8:00 a.m. Eastern Time (ET).
The Company is actively evaluating the potential impact of COVID-19 on the business and plans to provide an update on the call. For additional information on Alexion’s ongoing efforts related to COVID-19, please visit: https://alexion.com/our-commitment/covid-19. Alexion intends to use this website as a means of disclosing material non-public information on COVID19 matters and for complying with its disclosure obligations under SEC Regulation FD. Accordingly, investors should monitor such portions of the Company’s website, in addition to following the Company’s press releases, SEC filings and public conference calls and webcasts.
To participate in this conference call, dial (866) 762-3111 (USA) or (210) 874-7712 (International), conference ID 1645087 shortly before 8:00 a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com and an archived version will be available for a limited time following the presentation.
2020 Annual Shareholder Meeting
Alexion will host its 2020 annual meeting of shareholders virtually due to the public health impact of the coronavirus pandemic and to prioritize the health and well-being of meeting participants.
The 2020 annual meeting of shareholders will be held in a virtual format only at 5:30 p.m. (ET) on Wednesday, May 13, 2020. Shareholders will not be able to attend the 2020 annual meeting in person.
Shareholders at the close of business on the record date, March 16, 2020, are entitled to attend the 2020 annual meeting. To be admitted to the meeting at www.virtualshareholdermeeting.com/ALXN2020, shareholders must enter the 16-digit voting control number found on their proxy card, voting instruction form, notice of internet availability of proxy materials or email previously received.
Please note that the proxy card and voting instruction form included with previously distributed proxy materials will not be updated to reflect the change from an in-person meeting to a virtual-only meeting and may be used to vote shares in connection with the annual meeting. Whether or not shareholders plan to attend the virtual-only annual meeting, Alexion urges shareholders to vote and submit their proxies in advance of the meeting by one of the methods described in the proxy materials.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200409005833/en/
Head of Investor Relations
Source: Alexion Pharmaceuticals, Inc.
View this news release online at: